课题基金 / 基金详情

BIOLOGY OF SCHIZOPHRENIA & MOOD DISORDERS IN FAMILIES

BIOLOGY OF SCHIZOPHRENIA & MOOD DISORDERS IN FAMILIES
精神分裂症的生物学
批准号:
3428746
负责人:
MATCHERI S. KESHAVAN
金额:
$3.48万
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-09-01 至 1988-08-31

项目摘要

项目成果

MATCHERI S. KESHAVAN的其他基金

相似基金

相关文献

中文摘要
翻译
这项初步研究的主要目的是研究 假设有家族病史的精神分裂症患者 情感障碍构成了一种神经生物学上的离散 精神分裂症综合征的亚群,并可能表现为 神经内分泌和睡眠异常类似于 情感障碍。 我们计划研究一组被诊断为 有严重抑郁障碍家族史的RDC标准 一位一级亲属的双相情感障碍(第1组:n=15) 将他们与一组诊断相似的精神分裂症患者进行比较 有一级精神分裂症病史的患者 相对(第2组:N-15),涉及以下参数: A)已知的两项神经内分泌测试在#年经常异常 情感障碍,即地塞米松抑制试验 (DST)和促甲状腺激素释放激素(TRH)挑战 测试和,b)多导睡眠图记录。 这项研究中检验的具体假设是,第一组将 地塞米松无抑制,对TSH反应迟钝 TRH和异常短的快速眼动(REM)睡眠 潜伏期比第二组更频繁。这项研究的发现 可能1)帮助描述具有病因学意义的亚群 异质性精神分裂症综合征和,2)帮助 确定在治疗上可能有所不同的特定亚组 反应性和预后。
英文摘要
The major objective of this pilot study is to examine the hypothesis that schizophrenic patients with a family history of affective disorders constitute a neurobiologically discrete subgroup of the schizophrenic syndrome, and may manifest neuroendocrine and sleep abnormalities similar to those seen in affective disorders. We plan to study a group of schizophrenic patients diagnosed by RDC criteria with family histories of major depressive disorder or bipolar disorder in a first degree relative (Group 1: n=15) and compare them with a group of similarly diagnosed schizophrenic patients with a history of schizophrenic illness in a first degree relative (Group 2: n-15), with respect to the following parameters: a) Two neuroendocrine test known to be frequently abnormal in affective disorders, namely the Dexamethasone Suppression Test (DST) and the Thyrotropin Releasing Hormone (TRH) Challenge Test and, b) Sleep Polysomnographic Records. The specific hypothesis tested in this study is that Group 1 will show dexamethasone nonsuppression, blunted TSH responses to TRH, and abnormally short Rapid Eye Movement (REM) sleep latency more frequently than Group 2. The findings of this study are likely 1) to help delineate aetiologically meaningful subgroups within the heterogeneous schizophrenic syndrome and, 2) to help identify specific subgroups that may differ in treatment responsiveness and prognosis.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Electroencephalographic sleep and cerebral morphology in functional psychoses: a preliminary study with computed tomography.
功能性精神病中的脑电图睡眠和大脑形态:计算机断层扫描的初步研究。
DOI: 10.1016/0165-1781(91)90095-7
发表时间: 1991
期刊: Psychiatry research
影响因子: 11.3
作者: [Keshavan,MS, Reynolds3rd,CF, Ganguli,R, Brar,J, Houck,P]
通讯作者: Houck,P
Plasma cholinesterase isozymes and REM latency in schizophrenia.
精神分裂症的血浆胆碱酯酶同工酶和 REM 潜伏期。
DOI: 10.1016/0165-1781(92)90138-s
发表时间: 1992
期刊: Psychiatry research
影响因子: 11.3
作者: [Keshavan,MS, Mahadik,SP, Reynolds3rd,CF, Mukerjee,S, Korenovsky,A, Houck,P, Jarrett,DB]
通讯作者: Jarrett,DB
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS)
4/5: Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (CLOZAPINE)
4/5: Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (CLOZAPINE)
Longitudinal trajectories in treated and untreated schizophrenia
  • 批准号:
    10306962
  • 项目类别:
  • 资助金额:
    $64.17万
  • 财政年份:
    2021
  • 负责人:
    MATCHERI S. KESHAVAN
  • 依托单位:
海外基金